Forty-four patients with advanced esophageal squamous cell carcinoma were treated with biochemical modulated combination chemotherapy and surgery. Treatment consisted of cisplatinum (70 mg/m 2 /day 1, day 22), 5-fluorouracil (5-FU; 700 mg/m 2 /day, days 1-5, 22-26), and leucovorin (20 mg/m 2 /day, d
Assessment of neoadjuvant chemotherapy for patients with advanced squamous cell carcinoma of the esophagus
β Scribed by Masahiko Yano; Masaaki Motoori; Koji Tanaka; Kentaro Kishi; Isao Miyashiro; Hidetoshi Eguchi; Terumasa Yamada; Masayuki Ohue; Hiroaki Ohigashi; Osamu Ishikawa
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 298 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1612-9059
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The combination of cisplatin and cytosine arabinoside has been shown in experimental models to be synergistic. We conducted a pilot study of cytosine arabinoside and cisplatin in unresectable or metastatic cancer of the esophagus in five patients and found significant activity, also on
## Abstract ## Background We investigated whether preoperative neoadjuvant chemotherapy is associated with increased surgical site infection (SSI) rate in patients with locally advanced oral cancer. ## Methods In this hospitalβbased study, we retrospectively reviewed over 2000 chart records of p
## Abstract Based on our previous demonstration that elevated cyclooxygenaseβ2 (COXβ2) expression is a prognostic factor for reduced survival in patients with adenocarcinoma of the esophagus, the aim of our study was to analyze the role of COXβ2 expression in esophageal squamous cell carcinoma. We